FDA Adverse Event Injury Summary report: N

XCELA

MDR report key: 23831169 · Received December 17, 2025

Report

Report Number
3008797795-2025-00043
Event Type
Injury
Date Received
December 17, 2025
Date of Event
January 1, 2017
Report Date
December 17, 2025
Manufacturer
PFM MEDICAL CPP SA
Product Code
LJT
PMA / PMN Number
K072481
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

THE MANUFACTURER CONDUCTED A DOCUMENTARY REVIEW ON THE BATCH PROVIDED: NO DEVIATION WAS FOUND. WITHOUT RETURNED PRODUCT FOR TECHNICAL INVESTIGATION, IT IS NOT POSSIBLE TO CONFIRM THE REPORTED DEFECT. THE RELATED RISKS ARE IDENTIFIED IN OUR RISK MANAGEMENT FILE AND PROCEDURE CLEARLY DESCRIBED IN THE IFU. THEREFORE, COMPLAINT IS CLASSIFIED AS NO DEFINITIVE CONCLUSION, UNVERIFIABLE (NO RETURN PRODUCT).

Description of Event or Problem · 0

ON OR ABOUT (B)(6) 2013, PATIENT UNDERWENT PLACEMENT OF THE OF THE ANGIODYNAMICS XCELA PORT, LOT NUMBER 130850. THE DEVICE WAS IMPLANTED AT (B)(6). IN 2017, HER PORT WAS SUBSEQUENTLY REMOVED DUE TO INFECTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2182506 XCELA PORT LJT PFM MEDICAL CPP SA 130850

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention| L